Year in Review: Cutting Edge Advances in Kidney Cancer - Imaging and…

Ketan Badani

Year in Review 2024 - Renal Cell Carcinoma

Oncology 2024 Year in Review

N. Mar

Clinical Highlights From AACR 2024: Trials Evaluating Selected New T…

AdventHealth

G. Sonpavde

Year in Review 2024 - 1L Combination Therapies for aRCC

Oncology 2024 Year in Review

Y. Zakharia

Recent GU Developments and Their Clinical Implications

Insights from 2024 ASCO® GU Annual Meeting

T. Powles, B. Rini

Treatment (De)Intensification in RCC

International Urology Cancer Summit - IUCS

S. Kumar Pal

No Role to Continue ICI Beyond Progression: CONTACT-03 & TiNivo-2 Ph…

Dana-Farber Cancer Institute

B. McGregor

ESMO 2024 Summary: Developmental Therapeutics Highlights

2024 ESMO Annual Meeting Insights Hub

G. Sonpavde

Hyperprogression in Cancer Treated With Immunotherapy

Northwestern Medicine Oncology and Hematology

Y. Chae

Updating Treatment Sequencing for mRCC

International Urology Cancer Summit - IUCS

N. Vasudev

ASCO® 2024 Summary: "Current Updates in RCC - Clinical Implications …

2024 ASCO® Annual Meeting Insights Hub

K. Mittal

Year in Review: Kidney Cancer - 2024 Insights and Exciting Prospects…

Jason Hafron

ASCO® GU 2025 Summary: Biomarkers in RCC - Current State and Future …

Insights from 2025 ASCO® GU Annual Meeting

S. Salami

ESMO 2024 Summary: Important GU Trials - ETER100 (RCC), TACITO (mRCC…

2024 ESMO Annual Meeting Insights Hub

C. Porta

The Surgeon's Management of Advanced Kidney Cancer

Daniel Shapiro

SIU 2024 Insights: Partial Nephrectomy - Open, Laparoscopic or Robot…

Miguel Ramos

ASCO® GU 2025 Summary: Striving Toward New Frontiers in Clear Cell K…

Insights from 2025 ASCO® GU Annual Meeting

T. Zhang

Best of Bladder Cancer and RCC From ESMO 2023 and GU ASCO 2024

Total Health

M. Reimers